Stability characteristics of cannabidiol for the design of pharmacological, biochemical and pharmaceutical studies.
Cannabidiol (CBD) is one of the most promising cannabinoids in therapeutics. Nevertheless, the reported stability testing has been carried out with plant extracts and not with CBD as a drug substance. The aim of this work was to evaluate the stability of CBD in solution. A High-Performance Liquid Chromatography (HPLC) analytical method, with CBD in ethanol, was previously validated for these stability studies. The resulting method was linear and proportional in a range of concentrations from 1 to 150 µg CBD/mL, as well as precise. It was also considered suitable to quantify CBD in aqueous medium as reported in accuracy studies. The stability of CBD was influenced by multiple factors. Temperature was one of the most critical parameters, with an activation energy of 92.19KJ/mol. At room temperature, CBD was highly unstable (t95 = 117.13 days). However, at 5 °C it was stable for at least 12 months. CBD was also sensitive to oxidation, with a short t95 of 1.77 days in oxidizing environments, as well as to light. The photolytic reaction seems to be oxidative. The solvent influences CBD stability, and the latter is more stable in ethanol than in aqueous medium. In fact, in simulated physiological conditions (pH 7.4 and 37 °C) 10% of CBD was degraded within 24 h. These studies indicate that CBD is highly unstable, and this should be taken into account in the development of in vitro and in vivo studies of CBD activity and in the pharmaceutical development of dosage forms.
Keywords: Cannabidiol; Degradation; HPLC; Oxidation; Shelf-life; Stability.
Copyright © 2020 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Quality Traits of « Cannabidiol Oils »: Cannabinoids Content, Terpene Fingerprint and Oxidation Stability of European Commercially Available Preparations.
Molecules. 2018 May 20;23(5):1230. doi: 10.3390/molecules23051230. Molecules. 2018. PMID: 29783790 Free PMC article.
A reliable and validated LC-MS/MS method for the simultaneous quantification of 4 cannabinoids in 40 consumer products.
PLoS One. 2018 May 2;13(5):e0196396. doi: 10.1371/journal.pone.0196396. eCollection 2018. PLoS One. 2018. PMID: 29718956 Free PMC article.
Therapeutic Use of Δ9-THC and Cannabidiol: Evaluation of a New Extraction Procedure for the Preparation of Cannabis-based Olive Oil.
Curr Pharm Biotechnol. 2017;18(10):828-833. doi: 10.2174/1389201019666171129175655. Curr Pharm Biotechnol. 2017. PMID: 29189144
Conversion of Cannabidiol (CBD) into Psychotropic Cannabinoids Including Tetrahydrocannabinol (THC): A Controversy in the Scientific Literature.
Toxics. 2020 Jun 3;8(2):E41. doi: 10.3390/toxics8020041. Toxics. 2020. PMID: 32503116 Review.
Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age.
Front Immunol. 2018 Sep 21;9:2009. doi: 10.3389/fimmu.2018.02009. eCollection 2018. Front Immunol. 2018. PMID: 30298064 Free PMC article. Review.
L’article Stability characteristics of cannabidiol for the design of pharmacological, biochemical and pharmaceutical studies. est apparu en premier sur Cannabis Belgique.